Dashboard
1
Positive results in Sep 25
- ROCE(HY) Highest at 16.91%
- INVENTORY TURNOVER RATIO(HY) Highest at 2.23 times
- RAW MATERIAL COST(Y) Fallen by -1.31% (YoY)
2
With ROE of 15.85%, it has a very attractive valuation with a 2.97 Price to Book Value
3
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 35,863 Million (Large Cap)
19.00
NA
4.57%
-0.82
16.97%
3.61
Revenue and Profits:
Net Sales:
1,814 Million
(Quarterly Results - Mar 2026)
Net Profit:
455 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.31%
0%
-1.31%
6 Months
11.05%
0%
11.05%
1 Year
-2.93%
0%
-2.93%
2 Years
-24.09%
0%
-24.09%
3 Years
2.29%
0%
2.29%
4 Years
77.68%
0%
77.68%
5 Years
60.8%
0%
60.8%
Dong-E-E-Jiao Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.00%
EBIT Growth (5y)
33.09%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.52
Tax Ratio
16.52%
Dividend Payout Ratio
99.84%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.60%
ROE (avg)
8.42%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.97
EV to EBIT
12.46
EV to EBITDA
11.44
EV to Capital Employed
13.83
EV to Sales
3.57
PEG Ratio
0.94
Dividend Yield
5.34%
ROCE (Latest)
111.04%
ROE (Latest)
15.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,814.20
1,934.10
-6.20%
Operating Profit (PBDIT) excl Other Income
516.30
617.00
-16.32%
Interest
0.90
4.40
-79.55%
Exceptional Items
-11.70
8.90
-231.46%
Consolidate Net Profit
454.80
461.90
-1.54%
Operating Profit Margin (Excl OI)
284.60%
296.60%
-1.20%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -6.20% vs 12.73% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -1.54% vs 0.63% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
6,643.70
6,106.90
8.79%
Operating Profit (PBDIT) excl Other Income
2,100.90
1,794.60
17.07%
Interest
6.80
8.10
-16.05%
Exceptional Items
-8.50
18.20
-146.70%
Consolidate Net Profit
1,738.70
1,557.30
11.65%
Operating Profit Margin (Excl OI)
292.10%
268.20%
2.39%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 8.79% vs 30.65% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 11.65% vs 35.21% in Dec 2024
About Dong-E-E-Jiao Co., Ltd. 
Dong-E-E-Jiao Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






